Neurol. praxi. 2018;19(2):92-95 | DOI: 10.36290/neu.2018.146

Genetic causes of epilepsy

MUDr. Katalin Štěrbová1, MUDr. Petra Laššuthová, Ph.D.2, MUDr. Markéta Vlčková, Ph.D.3
1 Klinika dětské neurologie, 2. LF UK a FN Motol, Praha
2 DNA laboratoř, Klinika dětské neurologie, 2. LF UK a FN Motol, Praha
3 Ústav biologie a lékařské genetiky, 2. LF UK a FN Motol, Praha

Current progress in genetic technologies increases the detection rate of genetic causes of epilepsies, especially of early infantileonset epilepsies associated with comorbidities. Cooperation of neurologists with clinical geneticists and molecular biologist isessential for correct interpretation of the results.

Keywords: epilepsy, genetics, next generation sequencing

Received: February 22, 2019; Accepted: April 23, 2019; Prepublished online: April 23, 2019; Published: May 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Štěrbová K, Laššuthová P, Vlčková M. Genetic causes of epilepsy. Neurol. praxi. 2018;19(2):92-95. doi: 10.36290/neu.2018.146.
Download citation

References

  1. Bray PF, Wiser WC. Hereditary characteristics of familial temporal-central focal epilepsy. Pediatrics 1965; 36(2): 207-211. Go to original source... Go to PubMed...
  2. Buysse K, Delle Chiaie B, Van Coster R, Loeys B, De Paepe A, Mortier G, Speleman F, Menten B. Challenges for CNV interpretation in clinical molecular karyotyping: lessons learned from a 1001 sample experience. Eur J Med Genet. 2009; 52(6): 398-403. Go to original source... Go to PubMed...
  3. Helbig I. The story of the missed SCN1A mutations. Publikováno online 28. 4. 2016, dostupný na http://epilepsygenetics.net/2016/04/28/the-story-of-the-missed-scn1a-mutations/.
  4. Koeleman BPC. What do genetic studies tell us about the heritable basis of common epilepsy? Polygenic or complex epilepsy? Neurosci. Lett. (2017), article in press. Go to original source... Go to PubMed...
  5. OMIM Dravet syndrome # 607208 online dostupný na https://www.omim.org/entry/607208.
  6. Orsini A, Zara F, Striano P. Recent advances in epilepsy genetics. Neuroscience Letters 2017, article in press. Go to original source... Go to PubMed...
  7. Poduri A. When Should Genetic Testing Be Performed in Epilepsy Patients? Epilepsy Currents, 2017; 17(1): 16-22. Go to original source... Go to PubMed...
  8. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the american college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015; 17(5): 405-424. Go to original source... Go to PubMed...
  9. Rinaldi B, Vaisfeld A, Amarri S, Baldo C, Gobbi G, Magini P, Melli E, Neri G, Novara F, Pippucci T, Rizzi R, Soresina A, Zampini L, Zuffardi O, Crimi M. Guideline recommendations for diagnosis and clinical management of Ring14 syndrome - first report of an ad hoc taskforce. Orphanet Journal of Rare Diseases 2017; 12: 69. Go to original source... Go to PubMed...
  10. Sadleir L, Mountier EI, Gill D, Davis S, Joshi C, DeVile C, Kurian MA; DDD Study, Mandelstam S, Wirrell E, Nickels KC, Murali HR, Carvill G, Myers CT, Mefford HC, Scheffer IE. Not all SCN1A epileptic encephalopathies are Dravet syndrome. Neurology. 2017; 89(10): 1035-1042. Go to original source... Go to PubMed...
  11. Vignoli A, Bisulli F, Darra F, Mastrangelo M, Barba C, Giordano L, Turner K, Zambrelli E, Chiesa V, Bova S, Fiocchi I, Peron A, Naldi I, Milito G, Licchetta L, Tinuper P, Guerrini R, Dalla Bernardina B, Canevini MP. Epilepsy in ring chromosome 20 syndrome. Epilepsy Res. 2016; 128: 83-93. Go to original source... Go to PubMed...
  12. Wang JWang J, Lin ZJ, Liu L, Xu HQ, Shi YW, Yi YH, He N, Liao WP. Epilepsy-associated genes. Seizure 2017; 44: 11-20. Go to original source... Go to PubMed...
  13. Wolff M, Johannesen KM, Hedrich UBS, Masnada S, Rubboli G, Gardella E, Lesca G, Ville D, Milh M, Villard L, Afenjar A, Chantot-Bastaraud S, Mignot C, Lardennois C, Nava C, Schwarz N, Gérard M, Perrin L, Doummar D, Auvin S, Miranda MJ, Hempel M, Brilstra E, Knoers N, Verbeek N, van Kempen M, Braun KP, Mancini G, Biskup S, Hörtnagel K, Döcker M, Bast T, Loddenkemper T, Wong-Kisiel L, Baumeister FM, Fazeli W, Striano P, Dilena R, Fontana E, Zara F, Kurlemann G, Klepper J, Thoene JG, Arndt DH, Deconinck N, Schmitt-Mechelke T, Maier O, Muhle H, Wical B, Finetti C, Brückner R, Pietz J, Golla G, Jillella D, Linnet KM, Charles P, Moog U, ?iglane-Shlik E, Mantovani JF, Park K, Deprez M, Lederer D, Mary S, Scalais E, Selim L, Van Coster R, Lagae L, Nikanorova M, Hjalgrim H, Korenke GC, Trivisano M, Specchio N, Ceulemans B, Dorn T, Helbig KL, Hardies K, Stamberger H, de Jonghe P, Weckhuysen S, Lemke JR, Krägeloh-Mann I, Helbig I, Kluger G, Lerche H, M?ller RS. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders. Brain 2017: 140; 1316-1336. Go to original source... Go to PubMed...
  14. Xiong W, Zhou D. Progress in unraveling the genetic etiology of rolandic epilepsy. Seizure 2017; 47: 99-104. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.